
Migravin 250 Tablet
Marketer
Mavis Lifesciences
Salt Composition
Naproxen (250mg) + Domperidone (10mg)
Overview Migravin 250 Tablet
Cephalease 250mg tablets combine two active ingredients to prevent migraine attacks. This medication inhibits the release of pain-inducing chemicals, reducing inflammation and fever. It also suppresses brain signals triggering migraine-associated nausea and vomiting. Cephalease 250mg may be used independently or as part of a broader treatment plan. It can be taken with or without food; dosage and treatment length depend on individual response and symptom severity. Consistent use is crucial; discontinue only under your doctor's guidance. Common side effects, including flu-like symptoms, upset stomach, and dry mouth, may occur. Report persistent or worsening side effects to your physician, who can offer management strategies. Minimize dosage while effectively managing symptoms. Inform your doctor of any existing health conditions or medications before starting Cephalease 250mg, as interactions are possible. Exercise caution if you have liver or kidney disease, or a history of alcohol abuse. Pregnant or breastfeeding individuals should seek medical advice prior to use.
Uses of Migravin 250 Tablet
Migraine Prophylaxis
Major Benefits of Migravin 250 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Migravin 250 Tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Migravin 250 Tablet:
- Flu-like symptoms
- Indigestion
- Dryness in mouth
How to use Migravin 250 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Migravin 250 Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, although consistent timing is recommended.
How Migravin 250 Tablet works:
Migravin 250 Tablets contain Naproxen and Domperidone, two medications working synergistically to alleviate migraine symptoms. Naproxen, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of pain-inducing chemical messengers in the body, thus targeting migraine pain. Domperidone, a prokinetic agent, acts on the brain's vomiting center to quell migraine-associated nausea, while also facilitating improved gastrointestinal motility and food passage.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Migravin 250 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Migravin 250 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The medication Migravin 250 Tablet is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking Migravin 250 Tablets can lead to adverse reactions that impair driving skills. These reactions may include dizziness, fatigue, drowsiness, insomnia, or visual disturbances, all of which can negatively impact your ability to operate a vehicle.
KidneyCAUTION
For individuals with impaired kidney function, Migravin 250 Tablet requires careful administration. Dosage modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Individuals with liver impairment should use Migravin 250 Tablets cautiously, potentially requiring dosage modification under medical supervision. Migravin 250 Tablets are contraindicated for patients exhibiting moderate to severe hepatic dysfunction.
What if you forget to take Migravin 250 Tablet :
Should you forget a Migravin 250 Tablet dose, take it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Migravin 250 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Pain Relievers |
